2024 annual financial data
Syndax Pharmaceuticals 2024 Operating margin
Syndax Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was -1,434.43%.
Operating income was -339,672,000 USD and net income was -318,758,000 USD.
Operating cash flow was -274,903,000 USD.
Get free Syndax Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,680,000 USD
- Operating income
- -339,672,000 USD
- Net income
- -318,758,000 USD
- Operating cash flow
- -274,903,000 USD